Tianjin Zhongxin Pharmaceutical Group Corp Ltd
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmologic… Read more
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.012x
Based on the latest financial reports, Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a cash flow conversion efficiency ratio of 0.012x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥110.78 Million) by net assets (CN¥9.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Telix Pharmaceuticals Limited
PINK:TLPPF
|
0.064x |
|
Alior Bank S.A.
WAR:ALR
|
0.024x |
|
Hercules Capital Inc
NYSE:HTGC
|
0.036x |
|
Chunghwa Precision Test Tech Co Ltd
TWO:6510
|
0.053x |
|
TBC Bank Group PLC
PINK:TBCCF
|
0.003x |
|
Crane NXT Co
NYSE:CXT
|
0.020x |
|
K&S AG
OTCQX:KPLUF
|
0.038x |
|
APT Medical Inc
SHG:688617
|
0.077x |
Annual Cash Flow Conversion Efficiency for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.85 Billion | CN¥924.67 Million | 0.118x | +13.69% |
| 2023-12-31 | CN¥6.65 Billion | CN¥688.49 Million | 0.104x | +0.23% |
| 2022-12-31 | CN¥6.55 Billion | CN¥677.25 Million | 0.103x | -21.01% |
| 2021-12-31 | CN¥6.51 Billion | CN¥852.40 Million | 0.131x | +15.96% |
| 2020-12-31 | CN¥5.95 Billion | CN¥671.42 Million | 0.113x | +25.79% |
| 2019-12-31 | CN¥5.52 Billion | CN¥495.49 Million | 0.090x | +29.50% |
| 2018-12-31 | CN¥5.05 Billion | CN¥350.14 Million | 0.069x | +8165.98% |
| 2017-12-31 | CN¥4.63 Billion | CN¥-3.97 Million | -0.001x | -100.88% |
| 2016-12-31 | CN¥4.30 Billion | CN¥419.90 Million | 0.098x | +11.12% |
| 2015-12-31 | CN¥4.11 Billion | CN¥360.58 Million | 0.088x | -9.77% |
| 2014-12-31 | CN¥2.95 Billion | CN¥286.85 Million | 0.097x | +17.45% |
| 2013-12-31 | CN¥2.57 Billion | CN¥213.44 Million | 0.083x | +807.71% |
| 2012-12-31 | CN¥2.28 Billion | CN¥20.81 Million | 0.009x | -88.42% |
| 2011-12-31 | CN¥2.21 Billion | CN¥173.88 Million | 0.079x | +18.36% |
| 2010-12-31 | CN¥2.09 Billion | CN¥139.04 Million | 0.067x | +42.83% |
| 2009-12-31 | CN¥1.79 Billion | CN¥83.41 Million | 0.047x | -55.90% |
| 2008-12-31 | CN¥1.47 Billion | CN¥155.77 Million | 0.106x | +606.94% |
| 2007-12-31 | CN¥1.35 Billion | CN¥20.13 Million | 0.015x | +175.03% |
| 2006-12-31 | CN¥1.41 Billion | CN¥-28.08 Million | -0.020x | -114.84% |
| 2005-12-31 | CN¥1.95 Billion | CN¥261.91 Million | 0.134x | +2304.03% |
| 2004-12-31 | CN¥1.88 Billion | CN¥10.50 Million | 0.006x | -86.57% |
| 2003-12-31 | CN¥1.84 Billion | CN¥76.57 Million | 0.042x | -62.51% |
| 2002-12-31 | CN¥1.69 Billion | CN¥187.60 Million | 0.111x | +8.52% |
| 2001-12-31 | CN¥1.54 Billion | CN¥157.73 Million | 0.102x | -- |